Variable-Coated Drug-Resin Beads for Sustained Release Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing sustained release formulations, such as drug-resin complexes, face challenges in achieving consistent drug release due to factors like patient variability in gastrointestinal fluids, leading to dose dumping, excessive retardation, or incomplete drug release, which affects therapeutic efficacy and patient compliance.
Innovation Solution
The development of sustained release compositions comprising variably coated drug-resin complexes with different levels of barrier coatings, ensuring controlled drug release through a combination of coated and uncoated drug-resin complexes in specific proportions, avoiding dose dumping and excessive retardation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If uncoated drug-resin complexes are used, then drug release is rapid, but control over release rate is poor and dose dumping occurs
Solution Approach 1:
A polymer coating is applied to the drug-resin complex particles to form a flexible barrier layer that controls drug release. The coating acts as a rate-limiting barrier, providing reliable control over the release rate while preventing dose dumping, thus resolving the contradiction between rapid release and controlled release.
Solution Approach 2:
The invention creates a composite structure combining drug-resin complexes with a polymer coating layer. This composite material integrates the ion-exchange properties of the resin with the barrier properties of the polymer coating, achieving both rapid initial release characteristics and controlled sustained release.
2Reliability
If coated drug-resin complexes are used, then control over drug release is improved, but resin swelling causes coating rupture
Solution Approach 1:
The resin cross-linking parameter is optimized to balance ion-exchange capacity with structural stability. By adjusting the cross-linking degree, the resin maintains sufficient rigidity to prevent excessive swelling that would rupture the coating, while still allowing controlled drug release through the polymer barrier.
Solution Approach 2:
The polymer coating is designed with appropriate flexibility and adhesion properties to accommodate minor resin volume changes without rupturing. The coating formulation includes plasticizers or flexible polymer segments that allow the film to stretch slightly during resin swelling cycles, maintaining coating integrity while preserving controlled release functionality.
3Stability of the object's composition
If variable coating levels are applied, then consistent sustained release profile is achieved, but manufacturing complexity increases
Solution Approach 1:
The invention applies variable coating levels to different portions or batches of drug-resin complex particles, creating a distribution of release rates within the formulation. This local quality variation achieves consistent overall sustained release profiles by compensating for individual particle variability, while using relatively simple coating processes.
Solution Approach 2:
Instead of attempting to achieve uniform coating on every particle (which would require complex multi-step processes), the invention applies coating partially or with variability, allowing some particles to have different coating levels. This partial action approach achieves the desired release consistency through statistical averaging while simplifying the manufacturing process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides a sustained release profile that maintains consistent drug levels, reducing side effects and improving patient compliance by preventing rapid drug peaks and troughs, thus enhancing therapeutic efficacy and convenience.
Implementation Method 1
Drug-resin complexes prepared by interaction of cationic ion-exchange resins with basic drugs in their cationic form
Implementation Method 2
Attempts were therefore made to coat drug-resin complexes so as to provide a further diffusion barrier to drug release
Data Source
AI summary
Sustained release compositions comprising plurality of sustained release beads are disclosed. Particularly the sustained release beads comprise coated drug-resin complexes comprising drug-resin complexes of at least one active agent and at least one ion-exchange resin; coated with at least one release modifier.